Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-22

Clinical Trial Update: Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two dose levels of DFN-15 to placebo in migraine patients has completed. The document does not detail trial results in the provided snip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DFN-15 (DFN-15)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Migraine | Phase 2 | Status: COMPLETED